P

Pfizer

Makes cancer drugs, vaccines and other medicines

Production Technician 2

Full-Time
No salary listed
Entry
Bachelor's
Wuxi, Jiangsu, China
In Person
Biology & BiotechBioprocess & Biomanufacturing

About the job

Requirements
  • A bachelor's degree in a pharmaceutical, chemical, or related field.
  • Knowledge of pharmaceutical practices, Good Manufacturing Practices (GMP), validation, and applicable pharmaceutical, labor, and environmental regulations.
  • Ability to communicate and collaborate effectively and analyze information.
  • Good overall English proficiency and proficiency using computers and Microsoft Office.
  • Ability to learn and accept new knowledge and complete multiple tasks simultaneously.
  • Ability to work assigned early, mid, and night shifts under the factory's scheduling system.
Responsibilities
  • Perform sterile production work according to applicable standard operating procedures (SOPs) and batch production records.
  • Complete position logs and batch records in accordance with data-integrity requirements.
  • Coordinate and participate in sterile production activities to meet market demands for product quantity and quality while using available resources effectively.
  • Participate in batch record review.
  • Issue and return materials in the SAP system, and draft or revise SOPs.
  • Organize and coordinate production activities within the process area.
  • Train new employees and conduct periodic job-performance assessments for employees in the role area.
  • Ensure production processes comply with GMP requirements and Pfizer Quality Standards (PQS), and ensure operations follow SOPs.
  • Participate in and lead workers and employees in the daily use, cleaning, and maintenance of equipment.
  • Maintain safe and sanitary production conditions in accordance with national and company requirements and applicable controls.
  • Participate in and assist the management team with new-product trial production and commissioning new equipment.
  • Assist managers in developing training procedures and plans and ensure employees receive effective training through appropriate processes.
  • Continuously improve processes, equipment, and workflows to increase production efficiency and capacity and stabilize product quality.
  • Comply with company Environmental, Health, and Safety (EHS) policies and requirements, verify related work, and implement new verification activities.

About the company

P

Pfizer

View
Website

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-2%

2 year growth

-2%
Yahoo Finance
Oct 29th, 2026
HER2 targeted therapies market to hit $16.34B by 2030 on 8.6% CAGR

The global HER2 targeted therapies market is forecast to grow from $10.84 billion in 2025 to $11.75 billion in 2026, according to a Research and Markets report. It is expected to reach $16.34 billion by 2030, a compound annual growth rate (CAGR) of 8.6% from 2026. Demand for targeted cancer treatments, rising breast and gastric cancer rates, and wider use of monoclonal antibody therapies are driving growth. Precision oncology, broader biomarker testing, and next-generation antibody-drug conjugates should support it further. In February 2026, Boehringer Ingelheim won US Food and Drug Administration approval for HERNEXEOS (zongertinib) for HER2-mutant advanced non-small cell lung cancer. In December 2023, Pfizer bought Seagen for about $43 billion. North America led the market in 2025; Asia-Pacific is expected to grow fastest.

Yahoo Finance
Oct 29th, 2026
Edison Scientific to deploy Kosmos AI scientist across Pfizer's R&D pipeline

Edison Scientific has agreed to deploy its Edison AI Platform and Kosmos, its AI scientist, across Pfizer's biopharmaceutical research and development pipeline. The deal was announced in San Francisco on October 29, 2026. Kosmos will access Pfizer's data in areas including oncology, internal medicine, and immunology. It will support scientists, inform R&D decisions, and help speed the discovery of potential new medicines. Edison's scientists and engineers will work with Pfizer's research teams to build Kosmos into specific workflows. Kosmos will keep learning, combining public data with Pfizer's proprietary drug development data. "At Pfizer's scale, the opportunity to turn accumulated scientific experience into better decisions is extraordinary," said Sam Rodriques, chief executive officer of Edison Scientific. Edison spun out of the nonprofit lab FutureHouse in 2025 and is backed by $70 million from Spark Capital, Triatomic Capital, and other investors.

Yahoo Finance
Oct 27th, 2026
AT&T, Pfizer and Zoetis offer yields up to 5.8% with shares under $100

Rising interest rates and bond yields have made dividend stocks less appealing, pushing many lower and their yields higher. Three that trade below $100 are AT&T, Pfizer, and Zoetis, according to The Motley Fool. AT&T trades around $21, down about 16% this year, with a price-to-earnings (P/E) multiple of 11 against 23 for the S&P 500. It yields 5.3% after revenue grew more than 5% in the September quarter. Pfizer trades near $30 and yields 5.8%. Its forward P/E is 10, though its shares are down more than 30% over five years. Zoetis, down 37% this year, trades below $80 with a P/E of 13 and a yield of about 2.6%. Its payout ratio is around 34% of earnings, and it has 12 potential blockbusters in its pipeline.

Yahoo Finance
Oct 22nd, 2026
Pfizer's 5.7% yield signals risk: dividends took 108% of free cash flow vs Merck's 66%

Merck's dividend looks safer than Pfizer's, despite Pfizer's higher yield, according to a 24/7 Wall St. comparison. Pfizer yields about 5.7% against Merck's 2.2%. In 2025, Pfizer's dividends used 108% of free cash flow, while Merck's used 66%. In the first half of 2026, Merck's free cash flow covered 174% of its payout; Pfizer's covered about 51%. Merck has raised its quarterly dividend 39% since 2020, to $0.85. Pfizer's rose 13% and has been flat at $0.43 since January 2025. Pfizer is cheaper, at about 10 times 2026 earnings against Merck's 17. Pfizer targets a return to growth from 2029, while Merck's newer drugs are already selling.

Yahoo Finance
Oct 21st, 2026
Pfizer announces layoffs at Rocky Mount and Sanford sites, but gives no numbers

Pfizer has announced layoffs at its Rocky Mount and Sanford facilities in North Carolina, as part of a push to improve efficiency. It told employees of the cuts on Tuesday but did not say how many jobs will go, when, or in which departments. Rocky Mount makes sterile injectables, while Sanford focuses on vaccines and advanced biologics, including gene therapies. "Headcount reductions are a part of this initiative," Pfizer said, adding that it will give affected staff support services. "If indeed this happens, it's going to affect those families," said David Farris, president and chief executive officer of the Rocky Mount Area Chamber of Commerce. The impact on local economies, he said, depends on the number laid off. As of Wednesday afternoon, no Worker Adjustment and Retraining Notification (WARN) notice had been filed with the state.